Sustainability Is the New Survival Strategy
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
False
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 16, 2026
1 min read
Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology
October 15, 2026
8 min read
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
October 14, 2026
12 min read
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
October 12, 2026
2 min read
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
False
Affiliations:
Specialties:
Areas of Expertise: